Danfeng Xu
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Surgery
- Oncology top 10%
- Topics
- Prostate Cancer Treatment and Research (25 papers)Prostate Cancer Diagnosis and Treatment (22 papers)Renal cell carcinoma treatment (18 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCell Metabolism
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Danfeng Xu
132 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 898
- Pulmonary and Respiratory Medicine 579
- Cancer Research 442
- Surgery 273
- Oncology 255
Countries citing papers authored by Danfeng Xu
This map shows the geographic impact of Danfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Xu more than expected).
Fields of papers citing papers by Danfeng Xu
This network shows the impact of papers produced by Danfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Xu. The network helps show where Danfeng Xu may publish in the future.
Co-authorship network of co-authors of Danfeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Danfeng Xu. A scholar is included among the top collaborators of Danfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danfeng Xu. Danfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 24 | |
| 9 | 13 | |
| 10 | 11 | |
| 11 | Apogossypolone acts as a metastasis inhibitor via up-regulation of E-cadherin dependent on the GSK-3/AKT complex. | 5 |
| 12 | 4 | |
| 13 | 31 | |
| 14 | 13 | |
| 15 | 25 | |
| 16 | 15 | |
| 17 | 42 | |
| 18 | 8 | |
| 19 | 1 | |
| 20 | 29 |
About Danfeng Xu
Danfeng Xu is a scholar working on Cancer Research, Urology and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Renal cell carcinoma treatment (18 papers). The work is most often cited by research in Cancer Research (442 citations), Urology (162 citations) and Pulmonary and Respiratory Medicine (579 citations). Danfeng Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yi Gao, Hai Huang, Xiuwu Pan, Hong Yi, Yi Gao, Fajun Qu, Lu Chen, Xingang Cui, Hongchao He and Ling Li. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.